The Prevention and Early Detection of Cancer Network (PREDICT) Symposium
7 October 2025
The field of cancer prevention and early detection is rapidly evolving, requiring the collaboration of diverse roles, from basic researchers to clinical trial specialists, primary care providers, and specialist clinicians. Each contributor plays a vital part in improving patient outcomes, and our collective efforts ensure we remain at the cutting edge of knowledge and best practices.
The PREDICT Symposium will share insights on accelerating the translation of cancer prevention and early detection research into real-world impact.
Through dynamic keynotes, interactive panels, and case studies, we’ll explore how to:
- Deliver equitable, system-level implementation that reaches priority populations.
- Harness digital technologies, AI, and data integration to improve risk prediction and early detection.
- Build strong partnerships across health services, primary care, research, and communities.
- Overcome barriers in system readiness, workforce capability, and equity.
- Learn from global innovations in prevention and screening.
Sessions include:
- Equity in Action – Reaching priority populations and measuring what works
- Digital and Data-Driven Prevention – AI, risk stratification, and next-gen screening
- System Change & Implementation Science – Scaling innovations from pilot to policy
- Primary Care & Community Integration – Embedding prevention in everyday practice
- Global Perspectives – Lessons from international models
Chair
A/Prof Kara Britt
Lab Head, Breast Cancer Risk and Prevention Lab, Peter MacCallum Cancer Centre
This symposium was made possible with a grant from Tour De Cure
Silver Sponsors
Associate Professor Kara Britt
A/Prof Kara Britt
Lab Head, Breast Cancer Risk and Prevention Lab, Peter MacCallum Cancer Centre
A/Prof Britt leads the Breast Cancer Risk and Prevention Lab within the Cancer Evolution and Metastasis Program. She obtained her PhD from Monash University working on female reproductive endocrinology and undertook a CJ Martin fellowship at the Institute of Cancer Research (UK) under the mentorship of Alan Ashworth and Matthew Smalley. Her work has helped define why women in today’s society have an increased incidence of breast cancer. Her lab has been instrumental in developing pre-clinical models for prevention-based research.
A/Prof Britt has held Early and Mid-Career Victorian Cancer Agency Fellowships and a National Breast Cancer Foundation (NBCF) Early Career fellowship. Her work has been supported by NHMRC, Equity Trustees, NBCF, and the Basser Centre (USA). She also co-chairs the VCCC Accelerating Novel Therapies Program which aims to increase the number of new drugs translating through to the patients that need it most.
Resource details
This course is brought to you by
